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The studies about COVID-19 began to show that people who have already had COVID-19 were re-
admitted to the hospital due to COVID-19 positivity. This study aims to identify recurrent positive 
patients and the demographic characteristics of these patients. The number of recurrent COVID-19 
positive patients was 190. Of these patients, 97 (51.1%) were male, the average age was 44 years (±16), 
147 (77.4%) were never hospitalized, Of the hospitalized patients, 28 (65.1%) were male, and the 
average age of the inpatients was 54.67 years (±16.15). Looking at the duration of hospital stay of the 
inpatients, it was observed that the average was 11.16 days (±8.9). A positive correlation was found 
between the age of the patients and the duration of their hospital stay (r=0.386). The average time 
between the two positives was 53 days. Patients who have a recurrent positive result usually survive 
the disease with outpatient treatment for their mild illness. Hospitalization rates of male patients were 
higher than those of females, and the duration of hospital stay was found to increase as the age of the 
patients' increases.  
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INTRODUCTION 
The COVID-19 disease, which emerged 
in late 2019, spread all over the world and was 
declared as a pandemic, continued to have its 
impact throughout 2020. Numerous methods 
and constraints, such as international travel 
bans, closure of borders between countries, 
the need to wear a mask, social distancing, 
meeting bans, prohibition of collective 
activities, and curfew to reduce the spread of 
the virus.1,2 Despite all this, COVID-19 
disease continued to rise, although it 
sometimes reduced its impact regionally. 
Some countries have begun to discuss the 
second wave of COVID-19 and its effects.3 In 
addition to all the measures taken, intensive 
vaccine development activities have been 
started in many countries to cope with the 
virus, restricting our social life.4 Although 
there is no definitive experience of the 
effectiveness of vaccines yet, vaccine studies 
for a permanent solution continue to be 
followed by people with hope.          
 
 
Although the world was expecting relief, 
studies began to show that people who have 
already had COVID-19 were again admitted 
to the hospital due to COVID-19 positivity.5 
When someone who has had COVID-19 tests 
positive again for COVID-19? Is reinfection 
possible? How long antibodies protect us? 
How long will the protection last through the 
vaccines that induce antibodies in the fight 
against COVID-19? These questions come to 
mind without an answer yet. There must be a 
sufficient number of studies in the current 
medical literature on recurrent COVID-19 
cases to find answers to these questions. 
This study aims to identify whether there 
were recurrent RT-PCR positive patients who 
have tested positive for COVID-19 before, the 
demographic characteristics of these patients, 
the duration between recurrent positive test 
results, re-hospitalization status, and 
mortality. In this way, the study aims to 
contribute to the current medical literature in 
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terms of supporting the studies of valuable 
researchers looking for answers to the above-
mentioned questions. 
 
MATERIAL AND METHODS 
This study was conducted at the 1300-bed 
Sakarya University Training and Research 
Hospital (SEAH), the largest hospital in 
Sakarya province, which served as a 
pandemic hospital during the COVID-19 
pandemic. In SEAH, admission for the first 
suspected or symptomatic cases is handled in 
reserved areas in the emergency department. 
All cases tested positive again at least 14 days 
after the first RT-PCR positive test result, who 
were admitted to the SEAH emergency 
department from 19/03/2020, which is the 
time of the first Real-Time Reverse 
transcription-polymerase Chain Reaction 
(RT-PCR) positive COVID-19 case until 
05/01/2021 were included in the research. 
Undecided cases, those with typical chest 
tomography findings without a positive RT-
PCR test, and patients under the age of 18 
were excluded from the research. First 
nasopharyngeal and then oropharyngeal RT-
PCR samples were collected in a combined 
and sequential manner. 
According to the COVID-19 guidelines 
of the Ministry of Health in Turkey, 14 days 
of isolation were applied to patients who 
tested positive for COVID-19 RT-PCR in the 
first days of the pandemic, without requiring 
a negative RT-PCR test immediately after the 
treatment and isolation periods. Later, with 
the updates made in the guidelines, isolation 
was applied for ten days for outpatient 
patients, 14 days for patients hospitalized for 
more than one day in the service, and 20 days 
for patients hospitalized in intensive care. 
Therefore, since there was no routine to 
perform RT-PCR test again in the first 14 days 
for the patients who tested positive, patients 
whose time between two RT-PCR positives 
more than 14 days were included in the study. 
The data were obtained from the hospital 
automation system and patient files with the 
permission obtained from the SEAH Chief 
Physician Office on 14/01/2021 by paying 
attention to the confidentiality of personal 
data. The data obtained were evaluated using 
the IBM Statistical Package for the Social 
Sciences (SPSS) version 21 statistics 
program, and the Skewness and Kurtosis 
values in the range of -2/+2 were tested for 
compliance with the normal distribution of the 
data.6 The Pearson correlation test was used 
for the correlation of those within this 
interval. Values outside this range were 
considered to have non-normal distribution, 
and the Spearman correlation test was used for 
non-parametric correlation analysis. A Chi-
square test was used to compare categorical 
data. For the results, p<0.05 was considered 
statistically significant. A Scientific Research 
permit, dated 11/01/2021, was obtained from 
the Republic of Turkey Ministry of Health. 
 
RESULTS AND DISCUSSION 
The number of patients who tested 
positive for RT-PCR for the second time was 
190, with at least 15 days intervals during the 
study period. Of these patients, 97 (51.1%) 
were male, and 93 (48.9%) were female. The 
average age was 44 years (±16), the median 
age was 41.5 years, the minimum was 19 
years, and the maximum was 86 years. 
Of the patients, 147 (77.4%) were never 
hospitalized, and 43 (22.6%) were 
hospitalized at least once and treated. The 
hospitalization status of the patients is shown 
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Table 1. Hospitalization Status of Patients 
 







At the first admission 29 15.2 
At the second admission 7 3.7 
At both admissions 7 3.7 
Total 190 100 
 
A statistically notable distinction was 
found when the outpatient treatment was 
analyzed with the gender of the patients 
(p=0.036, See Table 2). Of the hospitalized 
patients, 28 (65.1%) were male, and 15 
(34.9%) were female. As 16.1% of female 
patients and 28.9% of male patients were 
hospitalized, it was observed that male 
patients were hospitalized at a higher rate. The 
average age of the inpatients was 55 years 
(±16), the median age was 55 years, the 
minimum was 25 years, and the maximum 
was 86 years. 
 









p Value Median 
Age 
Statistical Value 
Mortality Status Ex 6 1 0.0661 73 t(8,509)=-9,873,p<0.0052 
Alive 91 92 41 
Hospitalization Status Inpatient 28 15 0.0361 55 t(188)= -5,210,p<0.052 
Outpatient 69 78 38 
Hospital Unit3 Ward 18 13 0.1761 48 p= 0.0774 
ICU 5 0 72 
Ward+ICU 5 2 57 
Duration Between Two 
Positive Tests 
15-30 days 60 57 0.8701 46 p= 0.0544 
31-60 days 12 14 35 
61-90 days 7 8 36 
91 days < 18 14 36,5 
 
1Pearson Chi-Square test; 2 Independent t test; 3 Unit of inpatients; 4 Kruskal Wallis Test 
Of the inpatients, 31 (72.1%) received 
treatment only in the service, and 12 (27.9%) 
received treatment in intensive care. Looking 
at the duration of hospital stay of the 
inpatients, it was observed that the average 
was 11.16 days (±8.9), between a minimum of 
2 days and a maximum of 34 days. A weak 
but significant positive correlation was found 
between the age of the patients and the 
duration of their hospital stay (r=0.372). 
Accordingly, the duration of hospital stays 
increases as the age of patients increases. 
The average time between the two 
positives was 52.92 days, the median value 
was 21.5 days, the minimum was 15 days, and 
the maximum was 244 days. Of these patients, 
9 (4.7%) maintained their positivity despite 
hospitalization for 14 days. The average 
duration between two positive tests of patients 
in this group was 18.9 days (±5.01), between 
a minimum of 15 days and a maximum of 30 
days. Looking at the time between the two 
positives on a monthly basis, it is seen that 
117 patients (61.6%) tested positive for RT-
PCR again within the first 30 days. Only 59 
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patients (31.1%) were found to have a 
negative RT-PCR result between the two RT-
PCR positives. Of the patients, 131 patients 
(68.9%) had no negative RT-PCR results 
between two positive RT-PCR results. See 
Table 3 for two RT-PCR test positives and 
elapsed time between the two positives.  
 
 





There is a Negative in between1 
 





 Count Percent %
3 Count Percent %3 
 
Count  
15-30  26 13.68 91 47.89 117 61.57 
31-60  8 4.21 18 9.47 26 13.68 
61-90  7 3.68 8 4.21 15 7.89 
91< 18 9.47 14 7.36 32 16.84 
Total 59 31.05 131 68.94 190 100 
a Number of days between two positive RT-PCR test results; 1 There were negative RT-PCR test result(s) in between two 
positive RT-PCR tests; 2 No negative RT-PCR test results between the two positive RT-PCR tests; 3 It is the percentage 
value in the total number of patients. 
 
Looking at the mortality rates of the 
patients, 7 out of 190 patients (3.68%) 
decreased. Of the deceased patients, six were 
male (3.15% in total), and 1 (0.53% in total) 
was female. However, no statistically 
significant difference was found between the 
mortality status and the gender of the patients 
(p=0.119). The average age of these patients 
was 71.43 years (±6.99), and the median value 
was 73 years. Of the patients, five died in 
intensive care, 1 died in inpatient service, and 
1 in outpatient treatment. 
The issue that will need to be discussed 
most in this study is the time interval between 
positive RT-PCR results. Indeed, samples 
collected from 117 (61.57%) of 190 patients 
tested positive for RT-PCR within the first 30 
days. In this group of 117 patients, although 
26 patients tested negative for RT-PCR after 
the first positive RT-PCR result, they tested 
positive in the subsequent PCR tests. In the 
remaining 91 people of this group of 117 
patients, RT-PCR positivity was observed 
again in their subsequent admissions, 
regardless of whether there was a negative 
after the first positive RT-PCR result during 
their outpatient or inpatient treatment. In this 
case, how will we interpret this fact? Is there 
a false negative associated with the difficulty 
of taking the RT-PCR swab, or should we 
consider that patients who have tested 
negative are infected again within a month? 
In their systemic review of 2568 patients, 
Mahalul Azam et al. found a recurrent 
positive incidence of 14.8% and reported that 
the time from the onset of the disease to the 
date of re-positivity was an average of 35.4 
days, and the time between the last negative 
result and the re-positive result was 9.8 days.7 
Bo Yuan et al. also found that 20 (10.99%) out 
of 182 COVID-19 patients under medical 
isolation had recurrent positivity, of which 13 
tested positive on the 7th day and 7 of them 
on the 14th day.8 Tie-Jun Shui et al. examined 
758 COVID-19 patients who had at least two 
negative test result before being discharged 
from the hospital and concluded that 59 
patients (7.78%) tested positive again 33 days 
after their first admission on average.9 In a 
meta-analysis conducted by Tung Hoang, 
about 15% of 3644 discharged COVID-19 
patients were tested positive again at a later 
time.10 It has been noted by Steven Woloshin 
et al. that swab samples taken for COVID-19 
can give false-negative results at different 
rates.11 In addition, it has been reported that 
although there were negative results in the 
upper respiratory tract samples, positive 
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results continued to be obtained in 
gastrointestinal tract samples.12 Ai Tang Xiao 
et al. examined 70 COVID-19 patients who 
were tested positive again in their study and 
suggested that 15 (21.4%) may be false-
negative and that these patients may show 
positive again due to prolonged nucleic acid 
conversion.13 Since there were reports on the 
detection of the virus in the upper respiratory 
tract of the COVID-19 patients for at most 83 
days, Falahi and Kenarkoohi reported that 
positive results after 83 days could be 
considered reinfection if there was a 
symptom-free period between them; 
otherwise, it could be considered as a 
prolonged COVID-19 infection.14 
In a meta-analysis study, Muge Cevik et 
al. examined 79 COVID-19 studies and found 
that the average time to detect the virus in the 
upper respiratory tract, lower respiratory tract, 
feces, and serum was 17 days 14.6 days, 17.2 
days, and 16.6 days, respectively. In addition, 
they noted that the longest duration of time for 
virus positivity was 83 days, 59 days, 35 days, 
and 60 days, respectively, in the same areas.15 
In our study, 117 patients were found to 
be tested positive for RT-PCR again within 
the first 30 days, but 32 patients (16.84%) 
were RT-PCR positive in their re-admissions 
after 91 days and above. It is impossible to 
make a final decision on this issue until there 
is a guideline to help us decide which case is 
a prolonged COVID-19 infection and which 
case is reinfection. However, despite the 
negative RT-PCR test results in upper 
respiratory tract samples, it may be correct to 
consider the positive RT-PCR results within 
the first three months as the manifestation of 
a prolonged infection due to the fact that the 
virus can continue to exist in the 
gastrointestinal tract, and the virus can remain 
positive for up to 83 days. Moreover, although 
it is not certain, it is understood that further 
research and information is needed to 
consider the new positive test results that will 
occur in hospital admission after the first three 
months as a recurrent COVID-19 infection. 
Tie-Jun Shui et al. noted that patients who 
tested positive for the second time were 
mostly mild and moderately severe, while Bo 
Yuan et al. reported that recurrent positivity 
was more common in young people and 
asymptomatic.8,9 In line with this, Anna 
Gidari found that the mortality rate of the 
patients who were positive again was only 
2.1% in her research.16 As a result of the 
present study, 147 (77.4%) of the patients 
received outpatient treatment, only 12 patients 
(6.31%) needed intensive care, and the 
number of deaths was seven people (3.68%), 
which are in line with these results.  
 
CONCLUSION 
Recurrent positive RT-PCR can be 
observed in COVID-19 patients after their 
discharge. Although it is not yet possible to 
make a clear decision on whether this 
recurrent positivity is a symptom of a 
prolonged infection or reinfection, it is clear 
that further research is needed in this regard. 
Patients who have a recurrent positive result 
survive the disease with outpatient treatment 
for their mild illness. Hospitalization rates of 
male patients were higher than those of 
females, and the duration of hospital stay was 
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